Cargando…
AMP-activated protein kinase agonist N(6)-(3-hydroxyphenyl)adenosine protects against fulminant hepatitis by suppressing inflammation and apoptosis
Both AMP-activated protein kinase (AMPK) agonist and inhibitor have been reported to protect against fulminant hepatitis, implying that AMPK may play a complicated role in the development of fulminant hepatitis. In this study, we exploited whether the novel AMPK agonist N(6)-(3-hydroxyphenyl)adenosi...
Autores principales: | Li, Jin, Chen, Bo, Zhong, Liping, Gao, Feng, Zhu, Haibo, Wang, Fengzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833387/ https://www.ncbi.nlm.nih.gov/pubmed/29348606 http://dx.doi.org/10.1038/s41419-017-0118-0 |
Ejemplares similares
-
Dissecting the role of AMP-activated protein kinase in human diseases
por: Li, Jin, et al.
Publicado: (2017) -
Adenosine A(2A) Receptor Agonist Polydeoxyribonucleotide Alleviates Interstitial Cystitis-Induced Voiding Dysfunction by Suppressing Inflammation and Apoptosis in Rats
por: Ko, Il-Gyu, et al.
Publicado: (2021) -
The Effects of Berberine on Concanavalin A-Induced Autoimmune Hepatitis (AIH) in Mice and the Adenosine 5′-Monophosphate (AMP)-Activated Protein Kinase (AMPK) Pathway
por: Wang, Yangyang, et al.
Publicado: (2017) -
The Protective Effect of Cordycepin on D-Galactosamine/Lipopolysaccharide-Induced Acute Liver Injury
por: Li, Jin, et al.
Publicado: (2017) -
Fulminant hepatitis
por: Sinclair, Stephen, et al.
Publicado: (1990)